These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
☐
|
Preliminary
Proxy Statement
|
|
☐
|
Confidential,
For use of the Commission Only (as permitted by Rule
14a-6(e)(2))
|
|
☒
|
Definitive
Proxy Statement
|
|
☐
|
Definitive
Additional Materials
|
|
☐
|
Soliciting
Material Pursuant to §240.14a-12
|
|
☒
|
No fee
required.
|
|
|
☐
|
Fee
computed on table below per Exchange Act Rules 14a-6(i)(1) and
0-11.
|
|
|
|
|
|
|
|
(1)
|
Title
of each class of securities to which transaction
applies:
|
|
|
|
|
|
|
|
|
|
|
(2)
|
Aggregate
number of securities to which transaction applies:
|
|
|
|
|
|
|
|
|
|
|
(3)
|
Per
unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11(set forth the amount on
which the filing fee is calculated and state how it was
determined):
|
|
|
|
|
|
|
|
|
|
|
(4)
|
Proposed
maximum aggregate value of transaction:
|
|
|
|
|
|
|
|
|
|
|
(5)
|
Total
fee paid
|
|
|
|
|
|
|
|
|
|
☐
|
Fee
paid previously with preliminary materials:
|
|
|
|
|
|
|
|
|
|
|
☐
|
Check
box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting
fee was paid previously. Identify the previous filing by
registration statement number, or the Form or Schedule and the date
of its filing.
|
|
|
|
|
|
|
|
(1)
|
Amount
previously paid:
|
|
|
|
|
|
|
|
|
|
|
(2)
|
Form,
Schedule or Registration Statement No.:
|
|
|
|
|
|
|
|
|
|
|
(3)
|
Filing
Party:
|
|
|
|
|
|
|
|
|
|
|
(4)
|
Date
Filed:
|
|
|
|
|
|
Dear
Fellow
LightPath Stockholders:
|
September 27,
2021
|
|
|
|
|
By Internet
Visit
www.AALvote.com/LPTH
|
By Phone
Call
the telephone number on your proxy card, voting instruction form,
or notice
|
By Mail
Sign,
date, and return the enclosed proxy card or voting instruction
form
|
|
/s/ Shmuel Rubin
|
/s/ Louis Leeburg
|
|
Shmuel
Rubin
|
Louis
Leeburg
|
|
President
& Chief Executive Officer, Director
|
Chairman
of the Board
|
|
Proposal
|
Board
Recommendation
|
Voting
Choices
|
|
Vote
Required for Adoption
|
|
Effect
of Abstentions
|
Effect
of Broker Non-Votes
|
|
1
– Election of Director Nominees
|
FOR
each nominee
|
●
Vote
“For” any or all of the nominees listed
●
Vote
“Withhold” to withhold your vote for any or all
of the nominees listed
|
|
Plurality of the votes of the shares present in person or by proxy and entitled to vote at the Annual Meeting |
|
No effect |
No
effect
|
|
|
|
|
|
|
|
|
|
|
2
– Approval of the compensation of our named executive
officers
|
FOR
|
●
Vote
“For” the approval of the compensation of our named
executive officers
●
Vote
“Against” the approval of the compensation of our named
executive officers
●
Abstain
from voting on this proposal
|
|
Approved, on a
non-binding advisory basis, if a majority of the shares present in
person or represented by proxy and entitled to vote support the
proposal
|
|
Treated as votes
against proposal
|
No
effect
|
|
|
|
|
|
|
|
|
|
|
3
– Ratification of the appointment of MSL as our independent
registered public accounting firm
|
FOR
|
●
Vote “For” the ratification of
the appointment
●
Vote “Against” the ratification
of the appointment
●
Abstain from voting on this
proposal
|
|
Approved, on a
non-binding advisory basis, if a majority of the shares present in
person or represented by proxy and entitled to vote support the
proposal
|
|
Treated as votes
against proposal
|
Brokers have
discretion to vote
|
|
Name
|
Class
|
Audit
|
Compensation
|
Finance
|
Nominating & Corporate Governance
|
|
Dr. Joseph Menaker
|
I
|
☑
|
|
☑
|
|
|
Darcie Peck
|
I
|
☑
|
☑
|
|
|
|
Sohail Khan
|
II
|
|
|
☑
|
☑
|
|
M. Scott Faris
|
II
|
|
☑
|
☑
|
☑
|
|
S. Eric Creviston
|
II
|
|
☑
|
☑
|
|
|
Louis Leeburg, Chairman
|
III
|
|
☑
|
|
☑
|
|
Craig Dunham
|
III
|
☑
|
|
|
|
|
Shmuel Rubin
|
III
|
|
|
|
|
|
Committee Chairman:
|
|
Dunham
|
Leeburg
|
Khan
|
Leeburg
|
|
Sohail
Khan, 67
Director
|
Mr.
Khan has served as one of our directors since February 2005. In
October 2020, Mr. Khan joined II-VI Incorporated as Executive Vice
President, New Ventures & Wide-Bandgap Electronics Technologies
and is responsible for consolidating II-VI’s deep technology
expertise in silicon carbide (SiC) substrates, advanced
wide-bandgap epitaxy, device fabrication, and module design. Since
September 2017, he has served as the managing partner of K5
Innovations, a technology consulting venture. He also served in
such role from July 2011 to April 2013. He served as the President
and Chief Executive Officer of ViSX Systems Inc., a pioneer and
leader in media processing semiconductor solutions for video over
IP streaming solutions from September 2015 until the company was
acquired by Pixelworks in August 2017. From May 2013 to July 2014,
he served as the Chief Executive Officer and a director of
Lilliputian Systems, a developer of portable power products for
consumer electronics. He was the President and Chief Executive
Officer and a member of the board of directors of SiGe
Semiconductor (“SiGe”), a leader in silicon-based radio
frequency front-end solutions from April 2007 until it was acquired
by Skyworks Solutions Inc. in June 2011. Prior to SiGe, Mr. Khan
was Entrepreneur in Residence and Operating Partner of Bessemer
Venture Partners, a venture capital group focused on technology
investments. Mr. Khan received a Bachelor of Science in Electrical
Engineering from the University of Engineering and Technology in
Pakistan. Additionally, he received a Master’s of Business
Administration from the University of California at Berkeley. Mr.
Khan previously served on the board of directors and audit
committee of Intersil Corporation, a public company, from October
2014 to March 2017, and the board of directors of VIXS Systems,
Inc., a public company, until the acquisition by Renesas &
Pixelworks in August 2017. Mr. Khan’s experience in venture
financing, specifically technology investments, is an invaluable
asset Mr. Khan contributes to the Board composition. In addition,
Mr. Khan’s significant 35 years of experience in executive
management, particularly with respect to technology businesses,
profit and loss management, mergers and acquisitions, and capital
raising, as well as his background in engineering qualifies him for
service as one of our directors.
|
|
|
|
|
M.
Scott Faris, 56
Director
|
Mr.
Faris has served as a director of the Company since December 2011.
Mr. Faris is an experienced entrepreneur with almost two decades of
operating, venture-financing, and commercialization experience,
involving more than 20 start-up and emerging-growth technology
companies. In August 2021, Mr. Faris was appointed Chief Executive
Officer of ColdQuanta, Inc. Since September 2016, he has
served as Chief Business Officer of Luminar Technologies, Inc., a
leading developer of autonomous vehicle systems technologies
including Lidar sensor suites. In June 2013, Mr. Faris founded
Aerosonix, Inc. (formerly MicroVapor Devices, LLC), a privately
held developer and manufacturer of advanced medical devices, and
served as its Chief Executive Officer until August 2016 and has
served as Chairman of the board of directors since June 2013. In
2002, Mr. Faris also founded the Astralis Group, a strategy advisor
that provides consulting to start-up companies and, since 2004, Mr.
Faris has served as its Chief Executive Officer. In August 2007,
Mr. Faris founded Planar Energy, a company that developed
transformational ceramic solid-state battery technology and
products, and served as its Chief Executive Officer until June
2013. Planar Energy is a spin-out of the U.S. Department of
Energy’s National Renewable Energy Laboratory. From October
2004 to June 2007, Mr. Faris was a partner with Corporate IP
Ventures (formerly known as MetaTech Ventures), an early stage
venture fund specializing in defense technologies. Mr. Faris also
previously served as the Chairman and Chief Executive Officer of
Waveguide Solutions, a developer of planar optical light wave
circuit and micro system products, and as a director and Chief
Operating Officer of Ocean Optics, Inc., a
precision-optical-component and fiber-optic-instrument spin-out of
the University of South Florida. Mr. Faris was also the founder and
Chief Executive Officer of Enterprise Corporation, a technology
accelerator, served as a director of the Florida Seed Capital Fund
and Technology Commercialization at the Center for Microelectronics
Research, and the chairman of the Metro Orlando EDC. Mr. Faris
received a Bachelor of Science degree in Management Information
Systems from Penn State University in 1988. Mr. Faris is currently
on the board of directors of Aerosonix, Inc., a private company.
Mr. Faris’s significant experience in executive management
positions at various optical component companies, his experience in
the commercialization of optical and opto-electronic component
technology, and his background in optics, technology, and venture
capital qualify him for service as one of our
directors.
|
|
S. Eric
Creviston, 57
Director
|
Mr.
Creviston, has served as one of our directors since March 2021. He
has served as Corporate Vice President and President of Mobile
Products for Qorvo Inc. (“Qorvo”) since January 2015.
Prior to that, he served as the Corporate Vice President and
President of Cellular Products Group for RF Micro Devices, Inc.
(“RFMD”) from August 2007 to January 2015. From May
2002 to August 2007, he served as Corporate Vice President of
Cellular Products Group (previously known as Wireless Products
until 2004), for RFMD. Mr. Creviston received a Master’s
degree in Electrical and Electronics Engineering from the
University of Illinois. Mr. Creviston’s previous experience
in various leadership roles in Qorvo and RFMD will provide
invaluable knowledge to our Board with respect to assessing our
business strategies, evaluating operating performance, assessing
risks, and evaluating potential merger and acquisition
opportunities, all of which qualify him for service as one of our
directors.
|
|
Class III
Directors
|
|
|
Louis
Leeburg, 67
Chairman
|
Mr.
Leeburg has served as one of our directors since May 1996, and was
appointed Chairman, effective May 11, 2021. Mr. Leeburg is
currently a self-employed business consultant. Since 1993, Mr.
Leeburg has served as the senior financial advisor of The Fetzer
Institute, and before that, he served as the Vice President for
Finance. Mr. Leeburg was an audit manager for Price Waterhouse
& Co. until 1980. He is a member of Financial Foundation
Officers Group and the chairman and trustee for the John E. Fetzer
Memorial Trust Fund until it was ended on December 31, 2020. Mr.
Leeburg received a Bachelor of Science degree in Accounting from
Arizona State University. Mr. Leeburg has a broad range of
experience in accounting and financial matters. His expertise
gained in various roles in financial management and investment
oversight for over thirty years, coupled with his knowledge gained
as a certified public accountant, add invaluable knowledge to our
Board and qualify him for service as one of our
directors.
|
|
Craig
Dunham, 65
Director
|
Mr.
Dunham has served as one of our directors since April 2016, and
prior to his appointment to the Board, he served as a consultant to
the Board beginning in March 2014. Since April 2015, he has
provided business and M&A consulting to companies. From May
2011 until March 2015, Mr. Dunham served as the Chief Executive
Officer of Applied Pulsed Power Inc. (“APP”), a pulsed
power components and systems company near Ithaca, New York. Mr.
Dunham currently serves as a director of APP. From 2004 until 2011,
Mr. Dunham was President, Chief Executive Officer and director of
Dynasil Corporation of America (“Dynasil”), a company
which was previously listed on the Nasdaq Capital Market until
August 2019, and now is quoted on the OTC Markets Group,
Inc.’s Pink Open Market. He continues to be a director at
Dynasil and is a member of their audit committee. Prior to joining
Dynasil, Mr. Dunham spent approximately one year partnering with a
private equity group to pursue acquisitions of mid-market
manufacturing companies. From 2000 to 2003, he was Vice
President/General Manager of the Tubular Division at Kimble Glass
Corporation. From 1979 to 2000, he held progressively increasing
leadership responsibilities at Corning Incorporated
(“Corning”) in manufacturing, engineering, commercial,
and general management positions. At Corning, Mr. Dunham delivered
results in various glass and ceramics businesses including optics
and photonics businesses. Mr. Dunham earned a Bachelor of Science
degree in Mechanical Engineering and a Master’s degree in
Business Administration from Cornell University. Mr. Dunham’s
expertise in executive leadership, financial, strategic planning,
operations and management, business acumen, optics/photonics market
knowledge, and knowledge of the acquisitions process, qualifies him
for service as one of our directors.
|
|
|
|
|
Shmuel
Rubin, 46
President
& Chief Executive Officer, Director
|
Mr.
Rubin has served as our President, Chief Executive Officer, and as
a Director since March 2020. Mr. Rubin is also a director of
LightPath Optical Instrumentation (Shanghai) Co., Ltd.
(“LPOI”), our wholly-owned subsidiary located in
Jiading, People’s Republic of China, LightPath Optical
Instrumentation (Zhenjiang) Co., Ltd. (“LPOIZ”), our
wholly-owned subsidiary located in the New City District, of the
Jiangsu province of the People’s Republic of China, ISP
Optics Corporation (“ISP”), our wholly-owned
subsidiary, previously located in Irvington, New York, and ISP
Optics Latvia SIA (“ISP Latvia”), our wholly-owned
subsidiary located in Riga, Latvia.
Prior
to joining us, Mr. Rubin was formerly the General Manager at
Thorlabs Inc. (“Thorlabs”). In Mr. Rubin’s prior
senior executive role at Thorlabs, he was responsible for
Thorlabs’ Imaging Systems Division, a standalone organization
with its own sales and marketing, as well as global responsibility
for all of Thorlabs’ Life Science activities. Among the
positions he held at Thorlabs, Mr. Rubin founded and grew
Thorlabs’s fast growing operation in China, and spearheaded
Thorlabs’ entry and significant growth in the Life Sciences
market. As a member of the senior executive team, Mr. Rubin led new
strategic initiatives for Thorlabs, including new product lines,
acquisitions and growth into new markets. Prior to joining
Thorlabs, Mr. Rubin co-founded XLight Photonics, an optical
communication startup, which was later sold to a telecommunications
private equity firm. Mr. Rubin holds a Bachelor of Science degree
in Electronic Engineering from Ben Gurion University, a Master of
Business Administration degree from New York University, Stern
School of Business, and is a graduate of the Executive Education,
Program for Leadership Development at Harvard Business School. Mr.
Rubin’s significant management experience in the optical
industry qualifies him to lead us and our business and serve as one
of our directors.
|
|
Albert
Miranda, 54
Chief
Financial Officer
|
Mr.
Miranda was appointed as our Chief Financial Officer on May 7,
2021. Mr. Miranda was previously employed with Jenoptik North
America, Inc. (“Jenoptik”) for twelve years and held
the positions of President and Chief Financial Officer. Prior to
his employment with Jenoptik, he held senior level finance and
operational positions in optical products groups within Carl Zeiss
AG and served in the finance department for a division of BASF SE.
Mr. Miranda received a Master of Business Administration degree
with a major in Finance from Nova Southeastern University in
Florida and an undergraduate degree in Accounting from Pace
University in New York. He attained significant professional
experience and management expertise through key functional areas
encompassing finance, operations, business development, sales,
marketing, human resources, and information technology across a
broad group of products and services in demanding and diverse
industries including healthcare, defense and security, consumer
electronics, automotive, and semiconductors.
|
|
Louis
Leeburg
|
Sohail
Khan
|
|
M.
Scott Faris
|
Craig
Dunham
|
|
Darcie
Peck
|
Joseph
Menaker
|
|
S. Eric
Creviston
|
|
|
|
|
|
|
Securities
|
|
Percent
Owned
|
|||
|
|
Class
A Common Stock
|
|
|
|
(%)
|
|
|
Name
and Address (1)(10)
|
Restricted
(2)
|
Common
Stock
|
Stock
Options
|
Amount
of Shares of Class A Common Stock Beneficially Owned
|
|
|
|
Louis Leeburg,
Director
|
419,176
|
104,691
|
—
|
523,867
|
(3
)
|
1.9
%
|
|
Sohail Khan,
Director
|
420,376
|
20,661
|
—
|
441,037
|
|
1.6
%
|
|
M. Scott Faris,
Director
|
318,476
|
3,940
|
—
|
322,416
|
|
1.2
%
|
|
Craig Dunham,
Director
|
228,016
|
33,000
|
—
|
261,016
|
|
*
|
|
Dr. Joseph Menaker,
Director
|
103,009
|
—
|
—
|
103,009
|
|
*
|
|
Darcie Peck,
Director
|
54,222
|
16,000
|
—
|
70,222
|
|
*
|
|
S. Eric Creviston,
Director
|
15,328
|
—
|
—
|
15,328
|
|
*
|
|
Shmuel Rubin,
CEO
|
119,303
|
41,520
|
225,000
|
385,823
|
|
1.4
%
|
|
Albert Miranda,
CFO
|
—
|
4,000
|
75,000
|
79,000
|
|
*
|
|
Donald Retreage,
Jr., Former CFO
|
—
|
8,197
|
—
|
8,197
|
|
*
|
|
All
directors and executive officers currently holding office as a
group (10 persons)
|
1,677,906
|
232,009
|
300,000
|
2,209,915
|
|
7.6
%
|
|
Greater
than 5% beneficial owners:
|
|
|
|
|
|
|
|
Pudong Science and
Technology Investment (Cayman) Co., Ltd.
|
—
|
2,270,026
|
—
|
2,270,026
|
(4
)
|
8.4
%
|
|
Royce &
Associates, LP
|
—
|
1,463,884
|
—
|
1,463,884
|
|
5.4
%
|
|
Name
(1)
|
Class
A common stock
|
Stock
Options (2)
|
Restricted
Stock Units
|
Total
Amount of Shares of Class A Common Stock Beneficially
Owned
|
Stock
Price at June 30, 2021
|
Market
Value at June 30, 2021
|
Base
Salary
|
% of
Salary
|
|
Shmuel
Rubin
|
23,020
|
83,928
|
119,303
|
226,251
|
$
2.52
|
$
570,153
|
$
350,000
|
163
%
|
|
Albert
Miranda
|
—
|
—
|
—
|
—
|
$
2.52
|
$
-
|
$
200,000
|
0
%
|
|
Number of Points Earned
|
Percentage of Payout of the 2021 LT Multi-Year Award
|
|
0-3
|
0%
|
|
4
|
50%
|
|
5
|
60%
|
|
6
|
75%
|
|
7
|
100%
|
|
8
|
110%
|
|
9
|
125%
|
|
Number of Points Earned
|
Percentage of Payout of the 2020 LT Multi-Year Award
|
|
0-3
|
0%
|
|
4
|
50%
|
|
5
|
60%
|
|
6
|
75%
|
|
7
|
100%
|
|
8
|
110%
|
|
9
|
125%
|
|
|
|
|
|
|
|
|
|
Non-Equity
|
|
|
|
|
|
|
|
|
Stock
|
|
Option
|
|
Incentive
Plan
|
|
All Other
Compensation
|
|
|
Name
and Position
|
Fiscal
|
Salary
|
|
Awards
|
|
Awards
|
|
Compensation
|
|
Compensation
|
Total
|
|
|
Year
|
($)
|
|
($)
(1)
|
|
($)
(2)
|
|
($)
|
|
($)
(3)
|
($)
|
|
(a)
|
(b)
|
(c)
|
|
(e)
|
|
(f)
|
|
(g)
|
|
(i)
|
(j)
|
|
Shmuel
Rubin
|
2021
|
350,000
|
(5
)
|
21,716
|
(5
)
|
—
|
|
102,000
|
(9
)
|
15,340
|
489,056
|
|
President &
Chief Executive Officer
|
2020
|
105,464
|
(4
)
|
139,000
|
(4
)
|
197,987
|
(4
)
|
100,000
|
(4
)
|
48,075
|
590,526
|
|
Albert
Miranda
|
2021
|
34,615
|
(6
)
|
—
|
|
130,909
|
(6
)
|
—
|
|
—
|
165,524
|
|
Chief Financial
Officer
|
2020
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
—
|
|
Donald O. Retreage,
Jr.
|
2021
|
212,115
|
(7
)
|
—
|
|
—
|
|
—
|
|
—
|
212,115
|
|
Former Chief
Financial Officer
|
2020
|
200,000
|
(7
)
|
—
|
|
2,190
|
(8
)
|
28,800
|
(8
)
|
10,694
|
241,684
|
|
|
|
|
|
Compensation
Expense (1)
|
||||
|
|
|
|
|
Actual
|
Projected
|
Projected
|
Projected
|
Projected
|
|
|
Number
|
Number
of
|
|
Fiscal
2020
|
Fiscal
2021
|
Fiscal
2022
|
Fiscal
2023
|
Fiscal
2024
|
|
Grant Date
|
of
Shares
|
Vested
Shares
|
|
$
|
$
|
$
|
$
|
$
|
|
Stock
Option Grants
|
|
|
|
|
|
|
|
|
|
2/24/2020
|
225,000
|
50,000
|
(2
)
|
$
18,334
|
$
43,997
|
$
43,997
|
$
53,162
|
$
38,497
|
|
|
|
|
|
|
|
|
|
|
|
RSUs
|
|
|
|
|
|
|
|
|
|
2/24/2020
|
100,000
|
-
|
(3
)
|
$
9,654
|
$
23,169
|
$
23,169
|
$
42,470
|
$
40,538
|
|
1/28/2021
|
19,303
|
-
|
(4
)
|
-
|
4,344
|
8,687
|
8,685
|
-
|
|
|
|
|
|
$
9,654
|
$
27,513
|
$
31,856
|
$
51,155
|
$
40,538
|
|
Stock
Option Grants
|
|
|
Compensation
Expense (1)
|
||||
|
|
|
|
Actual
|
Projected
|
Projected
|
Projected
|
Projected
|
|
|
Number
|
Number
of
|
Fiscal
2021
|
Fiscal
2022
|
Fiscal
2023
|
Fiscal
2024
|
Fiscal
2025
|
|
Grant Date
|
of
Shares
|
Vested
Shares
|
$
|
$
|
$
|
$
|
$
|
|
4/19/2021
|
75,000
|
-
(2)
|
$
8,183
|
$
32,727
|
$
32,727
|
$
32,727
|
$
24,545
|
|
|
Option
Awards
|
RSU
Awards
|
|
||||
|
(a)
|
(b)
|
(c)
|
(e)
|
(f)
|
(g)
|
(h)
|
|
|
Name
|
Number of
Securities Underlying Unexercised Options (#)
Exercisable
|
Number of
Securities Underlying Unexercised Options (#)
Unexercisable
|
Option Exercise
Price ($)
|
Option Experation
Date
|
Number of
Shares or Units of Stock That Have Not
Vested
|
Market Value
of Shares or Units of Stock That Have Not
Vested
|
Vesting
Schedule
|
|
Shmuel
Rubin
|
50,000
|
175,000
|
$
1.58
|
|
|
|
50,000 shares/yr
for 3 yrs; 75,000 shares on 4th anniversary
|
|
|
|
|
|
2/24/2030
|
100,000
|
$
252,000
|
50,000
shares vest on 3rd and 4th anniversary
|
|
|
|
|
|
1/28/2031
|
19,303
|
$
48,644
|
3 yr vesting
with performance criteria
|
|
Albert
Miranda
|
—
|
75,000
|
$
3.02
|
4/19/2031
|
|
|
25%/yr for 4
yrs
|
|
Donald Retreage,
Jr. (1)
|
—
|
2,500
|
$
2.13
|
6/18/2028
|
|
|
25%/yr for 4
yrs
|
|
|
—
|
4,271
|
$
1.28
|
11/14/2029
|
|
|
33%/yr for 3
yrs
|
|
|
—
|
1,929
|
$
2.70
|
11/12/2030
|
|
|
33%/yr for 3
yrs
|
|
|
|
|
|
1/28/2031
|
5,534
|
$
13,946
|
3 yr vesting
with performance criteria
|
|
|
Fees Earned or
|
Stock
|
All
Other
|
|
|
|
|
Paid in
Cash
|
Awards
|
Compensation
|
Total
|
|
|
Name (1)
|
($)(2)
|
($)(5)
|
($)
|
($)
|
|
|
(a)
|
(b)
|
(c)
|
(g)
|
(h)
|
|
|
Robert
Ripp
|
$
100,000
|
(3
)
|
$
60,000
|
$
-
|
$
160,000
|
|
Louis
Leeburg
|
$
49,500
|
(4
)
|
$
60,000
|
$
-
|
$
109,500
|
|
Sohail
Khan
|
$
40,000
|
|
$
60,000
|
$
-
|
$
100,000
|
|
Dr. Steven
Brueck
|
$
27,000
|
(3
)
|
$
60,000
|
$
-
|
$
87,000
|
|
M. Scott
Faris
|
$
36,000
|
|
$
60,000
|
$
-
|
$
96,000
|
|
Craig
Dunham
|
$
40,000
|
|
$
60,000
|
$
-
|
$
100,000
|
|
Dr. Joseph
Menaker
|
$
36,000
|
|
$
60,000
|
$
-
|
$
96,000
|
|
Darcie
Peck
|
$
36,000
|
|
$
60,000
|
$
-
|
$
96,000
|
|
S. Eric
Creviston
|
$
13,500
|
(5
)
|
$
43,133
|
$
-
|
$
56,633
|
|
|
Board Fee
|
Chairman Fee
|
Committee Chair Fee
|
Total Fees Earned for Fiscal Year 2021
|
|
Robert
Ripp
|
$
36,000
|
$
60,000
|
$
4,000
|
$
100,000
|
|
Louis
Leeburg
|
$
36,000
|
$
7,500
|
$
6,000
|
$
49,500
|
|
Sohail
Khan
|
$
36,000
|
|
$
4,000
|
$
40,000
|
|
Dr.
Steven Brueck
|
$
27,000
|
|
|
$
27,000
|
|
M.
Scott Faris
|
$
36,000
|
|
|
$
36,000
|
|
Craig
Dunham
|
$
36,000
|
|
$
4,000
|
$
40,000
|
|
Dr.
Joseph Menaker
|
$
36,000
|
|
|
$
36,000
|
|
Darcie
Peck
|
$
36,000
|
|
|
$
36,000
|
|
S.
Eric Creviston
|
$
13,500
|
|
|
$
13,500
|
|
Shmuel
Rubin (1)
|
$
-
|
|
|
$
-
|
|
|
Restricted
Stock Units
|
|
|
|
Name
of Director (1)
|
Number of Units
Granted
|
Grant
Date
|
Fair Value Per
Share
|
|
Robert
Ripp
|
22,222
|
11/12/2020
|
$
2.70
|
|
Louis
Leeburg
|
22,222
|
11/12/2020
|
$
2.70
|
|
Sohail
Khan
|
22,222
|
11/12/2020
|
$
2.70
|
|
Dr. Steven
Brueck
|
22,222
|
11/12/2020
|
$
2.70
|
|
M. Scott
Faris
|
22,222
|
11/12/2020
|
$
2.70
|
|
Craig
Dunham
|
22,222
|
11/12/2020
|
$
2.70
|
|
Dr. Joseph
Menaker
|
22,222
|
11/12/2020
|
$
2.70
|
|
Darcie
Peck
|
22,222
|
11/12/2020
|
$
2.70
|
|
S. Eric
Creviston
|
15,328
|
6/25/2021
|
$
2.76
|
|
|
193,104
|
|
|
|
|
|
|
|
|
RSUs
|
|
|
Compensation
Expense (1)
|
||||
|
|
|
|
Actual
|
Actual
|
Projected
|
Projected
|
Projected
|
|
|
Number
of
|
Number
of
|
Fiscal
2020
|
Fiscal
2021
|
Fiscal
2022
|
Fiscal
2023
|
Fiscal
2024
|
|
Grant Date
|
Shares
|
Vested Shares
(2)
|
$
|
$
|
$
|
$
|
$
|
|
10/27/2016
|
38,462
|
38,462
|
$
4,998
|
$
-
|
$
-
|
$
-
|
$
-
|
|
10/26/2017
|
16,260
|
16,260
|
19,992
|
4,996
|
-
|
-
|
-
|
|
11/15/2018
|
32,787
|
32,787
|
20,000
|
26,665
|
-
|
-
|
-
|
|
11/14/2019
|
48,000
|
48,000
|
6,561
|
22,959
|
-
|
-
|
-
|
|
11/12/2020
|
22,222
|
22,222
|
-
|
60,000
|
-
|
-
|
-
|
|
|
|
|
$
51,552
|
$
114,620
|
$
-
|
$
-
|
$
-
|
|
RSUs
|
|
|
Compensation
Expense (1)
|
||||
|
|
|
|
Actual
|
Actual
|
Projected
|
Projected
|
Projected
|
|
|
Number
|
Number
of
|
Fiscal
2020
|
Fiscal
2021
|
Fiscal
2022
|
Fiscal
2023
|
Fiscal
2024
|
|
Grant Date
|
of
Shares
|
Vested Shares
(2)
|
$
|
$
|
$
|
$
|
$
|
|
10/27/2016
|
38,462
|
38,462
|
$
4,998
|
$
-
|
$
-
|
$
-
|
$
-
|
|
10/26/2017
|
16,260
|
16,260
|
19,992
|
4,996
|
-
|
-
|
-
|
|
11/15/2018
|
32,787
|
21,858
|
20,000
|
20,000
|
6,665
|
-
|
-
|
|
11/14/2019
|
48,000
|
16,000
|
6,561
|
9,840
|
9,840
|
3,279
|
-
|
|
11/12/2020
|
22,222
|
-
|
-
|
13,335
|
19,999
|
20,002
|
6,664
|
|
|
|
|
$
51,552
|
$
48,171
|
$
36,504
|
$
23,281
|
$
6,664
|
|
RSUs
|
|
|
Compensation
Expense (1)
|
||||
|
|
|
|
Actual
|
Actual
|
Projected
|
Projected
|
Projected
|
|
|
Number
|
Number
of
|
Fiscal
2020
|
Fiscal
2021
|
Fiscal
2022
|
Fiscal
2023
|
Fiscal
2024
|
|
Grant Date
|
of
Shares
|
Vested Shares
(2)
|
$
|
$
|
$
|
$
|
$
|
|
10/27/2016
|
38,462
|
38,462
|
$
4,998
|
$
-
|
$
-
|
$
-
|
$
-
|
|
10/26/2017
|
16,260
|
16,260
|
19,992
|
4,996
|
-
|
-
|
-
|
|
11/15/2018
|
32,787
|
21,858
|
20,000
|
20,000
|
6,665
|
-
|
-
|
|
11/14/2019
|
48,000
|
16,000
|
6,561
|
9,840
|
9,840
|
3,279
|
-
|
|
11/12/2020
|
22,222
|
-
|
-
|
13,335
|
19,999
|
20,002
|
6,664
|
|
|
|
|
$
51,552
|
$
48,171
|
$
36,504
|
$
23,281
|
$
6,664
|
|
RSUs
|
|
|
Compensation
Expense (1)
|
||||
|
|
|
|
Actual
|
Actual
|
Projected
|
Projected
|
Projected
|
|
|
Number
|
Number
of
|
Fiscal
2020
|
Fiscal
2021
|
Fiscal
2022
|
Fiscal
2023
|
Fiscal
2024
|
|
Grant Date
|
of
Shares
|
Vested Shares
(2)
|
$
|
$
|
$
|
$
|
$
|
|
10/27/2016
|
38,462
|
38,462
|
$
4,998
|
$
-
|
$
-
|
$
-
|
$
-
|
|
10/26/2017
|
16,260
|
16,260
|
19,992
|
4,996
|
-
|
-
|
-
|
|
11/15/2018
|
32,787
|
32,787
|
20,000
|
26,665
|
-
|
-
|
-
|
|
11/14/2019
|
48,000
|
48,000
|
6,561
|
22,959
|
-
|
-
|
-
|
|
11/12/2020
|
22,222
|
22,222
|
-
|
60,000
|
-
|
-
|
-
|
|
|
|
|
$
51,552
|
$
114,620
|
$
-
|
$
-
|
$
-
|
|
RSUs
|
|
|
Compensation
Expense (1)
|
||||
|
|
|
|
Actual
|
Actual
|
Projected
|
Projected
|
Projected
|
|
|
Number
|
Number
of
|
Fiscal
2020
|
Fiscal
2021
|
Fiscal
2022
|
Fiscal
2023
|
Fiscal
2024
|
|
Grant Date
|
of
Shares
|
Vested Shares
(2)
|
$
|
$
|
$
|
$
|
$
|
|
10/27/2016
|
38,462
|
38,462
|
$
4,998
|
$
-
|
$
-
|
$
-
|
$
-
|
|
10/26/2017
|
16,260
|
16,260
|
19,992
|
4,996
|
-
|
-
|
-
|
|
11/15/2018
|
32,787
|
21,858
|
20,000
|
20,000
|
6,665
|
-
|
-
|
|
11/14/2019
|
48,000
|
16,000
|
6,561
|
9,840
|
9,840
|
3,279
|
-
|
|
11/12/2020
|
22,222
|
-
|
-
|
13,335
|
19,999
|
20,002
|
6,664
|
|
|
|
|
$
51,552
|
$
48,171
|
$
36,504
|
$
23,281
|
$
6,664
|
|
RSUs
|
|
|
Compensation
Expense (2)
|
||||
|
|
|
|
Actual
|
Actual
|
Projected
|
Projected
|
Projected
|
|
|
Number
|
Number
of
|
Fiscal
2020
|
Fiscal
2021
|
Fiscal
2022
|
Fiscal
2023
|
Fiscal
2023
|
|
Grant Date
|
of
Shares
|
Vested Shares
(3)
|
$
|
$
|
$
|
$
|
$
|
|
10/27/2016
|
38,462
|
38,462
|
$
4,998
|
$
-
|
$
-
|
$
-
|
$
-
|
|
10/26/2017
|
16,260
|
16,260
|
19,992
|
4,996
|
-
|
-
|
-
|
|
11/15/2018
|
32,787
|
21,858
|
20,000
|
20,000
|
6,665
|
-
|
-
|
|
11/14/2019
|
48,000
|
16,000
|
6,561
|
9,840
|
9,840
|
3,279
|
-
|
|
11/12/2020
|
22,222
|
-
|
-
|
13,335
|
19,999
|
20,002
|
6,664
|
|
|
|
|
$
51,552
|
$
48,171
|
$
36,504
|
$
23,281
|
$
6,664
|
|
RSUs
|
|
|
Compensation
Expense (2)
|
||||
|
|
|
|
Actual
|
Actual
|
Projected
|
Projected
|
Projected
|
|
|
Number
|
Number
of
|
Fiscal
2020
|
Fiscal
2021
|
Fiscal
2022
|
Fiscal
2023
|
Fiscal
2024
|
|
Grant Date
|
of
Shares
|
Vested Shares
(3)
|
$
|
$
|
$
|
$
|
$
|
|
11/15/2018
|
32,787
|
21,858
|
$
20,000
|
$
20,000
|
$
6,665
|
$
-
|
$
-
|
|
11/14/2019
|
48,000
|
16,000
|
6,561
|
9,840
|
9,840
|
3,279
|
-
|
|
11/12/2020
|
22,222
|
-
|
-
|
13,335
|
19,999
|
20,002
|
6,664
|
|
|
|
|
$
26,561
|
$
43,175
|
$
36,504
|
$
23,281
|
$
6,664
|
|
RSUs
|
|
|
Compensation
Expense (2)
|
||||
|
|
|
|
Actual
|
Actual
|
Projected
|
Projected
|
Projected
|
|
|
Number
|
Number
of
|
Fiscal
2020
|
Fiscal
2021
|
Fiscal
2022
|
Fiscal
2023
|
Fiscal
2024
|
|
Grant Date
|
of
Shares
|
Vested Shares
(3)
|
$
|
$
|
$
|
$
|
$
|
|
11/14/2019
|
48,000
|
16,000
|
$
6,561
|
$
9,840
|
$
9,840
|
$
3,279
|
$
-
|
|
11/12/2020
|
22,222
|
-
|
-
|
13,335
|
19,999
|
20,002
|
6,664
|
|
|
|
|
$
6,561
|
$
23,175
|
$
29,839
|
$
23,281
|
$
6,664
|
|
RSUs
|
|
|
Compensation
Expense (1)
|
||||
|
|
|
|
Actual
|
Actual
|
Projected
|
Projected
|
Projected
|
|
|
Number
|
Number
of
|
Fiscal
2020
|
Fiscal
2021
|
Fiscal
2022
|
Fiscal
2023
|
Fiscal
2024
|
|
Grant Date
|
of
Shares
|
Vested Shares
(2)
|
$
|
$
|
$
|
$
|
$
|
|
6/25/2021
|
15,328
|
-
|
$
-
|
$
4,827
|
$
16,516
|
$
15,723
|
$
5,238
|
|
Plan
category
|
Number of
securities to be issued upon exercise of outstanding options,
warrants and rights
|
Weighted average
exercise and grant price of outstanding options, warrants and
rights
|
Number of
securities remaining available for future issuance
|
|
Equity compensation
plans approved by security holders
|
2,194,812
|
$
1.78
|
829,786
|
|
Equity compensation
plans not approved by security holders
|
—
|
—
|
—
|
|
|
Fiscal
2021
|
Fiscal
2020
|
|
Audit Fees
(1)
|
$
165,200
|
$
152,300
|
|
Tax Fees
(2)
|
22,500
|
22,500
|
|
All Other Fees
(3)
|
-
|
5,500
|
|
Total
All Fees (4)
|
$
187,700
|
$
180,300
|
|
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|